New Technology Quantitatively Analyzes Alzheimer's Biomarkers Using MR and PET Images
|
By MedImaging International staff writers Posted on 21 Jul 2023 |
|
A novel treatment for Alzheimer's disease utilizes an anti-amyloid antibody drug to reduce amyloid beta proteins in the brain. However, a common side effect, ARIA (Amyloid-Related Imaging Abnormalities), often appears in brain scans of patients using the drug. Therefore, careful monitoring and management of ARIA is crucial when prescribing anti-amyloid antibody drugs. Now, new cutting-edge brain imaging solutions for Alzheimer's disease treatment can enable the analysis of ARIA, thereby improving efficacy and outcomes.
Neurophet (Seoul, South Korea), an artificial intelligence (AI) solution company specializing in brain diseases, has developed a new technology to examine ARIA-E (edema) typically detected by T2-FLAIR, an MRI sequence, and ARIA-H (hemorrhages), primarily identified by GRE or SWI. An amyloid-PET scan is necessary to observe cortical amyloid beta deposition. Neurophet’s advanced technology predicts amyloid positivity through MR images before conducting amyloid-PET scans. The use of MR images for predicting amyloid positivity could provide a cost-effective solution for clinical trials and prognosis monitoring of Alzheimer's disease treatment, given that amyloid-PET scans are costly and their use and reimbursement are severely restricted. Moreover, PET scans are not universally accessible due to the limited availability of PET scanners.
At the recent Alzheimer's Association International Conference (AAIC) 2023, Neurophet showcased its cutting-edge brain imaging analysis technology, which can be applied in clinical trials and the prescription of new Alzheimer's disease drugs. The company's Neurophet AQUA software, a brain MRI analysis tool, analyzes brain atrophy observed in neurodegenerative diseases like Alzheimer's. Another product, the Neurophet SCALE PET software, quantitatively assesses Alzheimer's disease biomarkers using MR and PET images. It provides quantitative measurement of cortical amyloid beta deposition, a known causative agent of Alzheimer's disease. Neurophet is investing in research and development of analysis technology for ARIA side effects and aims to bring the products to market along with the launch of new Alzheimer's disease treatments.
"Neurophet's major products and technologies are expected to be very useful in the process of clinical trials, diagnosis, side effect monitoring and prognosis observation of Alzheimer's disease treatment." said CEO Jake Junkil Been of Neurophet. "We are going all out to develop solutions related to Alzheimer's disease treatment to preemptively target the high-growth Alzheimer's disease treatment market."
Related Links:
Neurophet
Latest MRI News
- AI Outperforms Radiologists in Detecting Prostate Cancer on MRI
- Non-Invasive Medical Imaging Test Predicts Dementia Nine Years before Diagnosis
- Self-Powered Sensor to Make MRIs More Efficient
- Low-Level Light Therapy Heals Serious Brain Injuries
- New AI Tool Detects Possible Metastatic Breast Cancer by Improving MRI Sensitivity
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
Channels
Radiography
view channel
Injury Prediction Rule Reduces Radiographic Imaging Exposure in Children
While cervical spine injuries (CSIs) are rare in children, they can have devastating consequences, such as quadriplegia, which is paralysis below the neck affecting both arms and legs. Diagnosing CSIs... Read more
AI Detects More Breast Cancers with Fewer False Positives
Mammography is essential for reducing breast cancer mortality but is associated with risks of false-positive results. Additionally, population-based mammography screening imposes a significant workload... Read more
AI-Powered Portable Thermal Imaging Solution Could Complement Mammography for Breast Cancer Screening
Breast cancer remains a major global health concern for women, with increasing incidence rates and mortality. In many low- and middle-income countries, the challenge is exacerbated by limited affordability... Read more
Ultrasound
view channel
Ultrasound Technology Breaks Blood-Brain Barrier for Glioblastoma Treatment
Despite extensive molecular studies, the outlook for patients diagnosed with the aggressive brain cancer known as glioblastoma (GBM) continues to be poor. This is partly due to the blood-brain barrier... Read more
Implantable Ultrasound Device Could Replace Electrodes for Deep Brain Stimulation
Deep brain stimulation with electrical impulses is an FDA-approved method for treating Parkinson’s disease symptoms. This technique involves using millimeter-thick electrodes to stimulate dopamine-producing... Read more
Robotic Ultrasound Systems to Assist Doctors during Surgery
Ultrasound technology was first introduced in medical diagnostics 60 years ago, with the introduction of the first remotely controllable ultrasound machine occurring 20 years ago. Now, the medical field... Read more
Functional Ultrasound Imaging Records Brain Activity through Transparent Skull Implant
Functional brain imaging, which captures brain activity data by measuring changes in blood flow or electrical impulses, provides crucial insights into brain function for both healthy individuals and those... Read moreNuclear Medicine
view channel
New PET Radiotracer Enables Same-Day Imaging of Key Gastrointestinal Cancer Biomarker
Gastrointestinal cancers rank among the most prevalent cancers worldwide, contributing to over a quarter of all cancer cases and over one-third of cancer-related deaths annually. The initial symptoms of... Read more
New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more![Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)](https://globetechcdn.com/mobile_medicalimaging/images/stories/articles/article_images/2024-05-09/JNM May 2024 Hofman.jpg "Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)"){kind=small}
New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more
General/Advanced Imaging
view channel
Artificial Intelligence Tool Enhances Usability of Medical Images
Doctors use myocardial perfusion imaging (MPI) single-photon emission computed tomography (SPECT) images to evaluate blood flow to the heart muscle. To capture these images, patients are administered a... Read more
New AI Tool Accurately Detects Six Different Cancer Types on Whole-Body PET/CT Scans
Automatic detection and characterization of cancer are crucial for initiating early treatment. The majority of artificial intelligence (AI) models designed to detect cancer rely on datasets that are either... Read more
Innovative Imaging Technique Helps Assess Bone Loss after Bariatric Surgery
Bariatric surgery provides substantial health improvements for individuals with severe obesity, although it is linked to bone mass reduction, potentially heightening the risk of fractures.... Read more
Imaging Software Improves Lung Diagnosis in Patients Allergic To Medical Contrast Dye
For up to 30% of patients who cannot use medical contrast dye due to allergies or other health conditions, diagnosing critical lung issues like pulmonary embolism can be delayed. This is because non-contrast... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Hologic, Inc. (Marlborough, MA, USA) has entered into a definitive agreement to acquire Endomagnetics Ltd. (Cambridge, UK), a privately held developer of breast cancer surgery technologies, for approximately... Read more
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
